Active	Status	Sponsor type	Region	Phase	Filter
9 Active 0 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

9 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cheung, Jim W
REACT-AF, NCT05836987: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation	Recruiting	3	5350	US	AFSW Guided DOAC, Apple Watch, Continuous DOAC therapy, Oral Anticoagulation therapy	Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI)	Atrial Fibrillation	07/29	07/29
NCT04170894: Radiofrequency Ablation of Atrial Fibrillation Under Apnea	Active, not recruiting	N/A	128	US	Periods of Apnea, Control Arm - No Periods of Apnea	Weill Medical College of Cornell University, Northwell Health, The Methodist Hospital Research Institute	Atrial Fibrillation	03/22	12/25
AVANT GUARD, NCT06096337: Pulsed Field Ablation (PFA) Vs Anti-Arrhythmic Drug (AAD) Therapy As a First Line Treatment for Persistent Atrial Fibrillation	Recruiting	N/A	520	Europe, Canada, US, RoW	FARAPULSE™ Pulsed Field Ablation (PFA) System, Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, Dofetilide, and Dronedarone	Boston Scientific Corporation	Persistent Atrial Fibrillation	12/25	12/27
NCT05977049: Psychosocial Support for Patients With Takotsubo Syndrome	Recruiting	N/A	24	US	Takotsubo Support Group	Weill Medical College of Cornell University	Takotsubo Cardiomyopathy	12/26	12/26
ADVANTAGE AF, NCT05443594: A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects with Persistent Atrial Fibrillation	Active, not recruiting	N/A	669	Europe, Canada, US	Phase 1: FARAPULSE Ablation System, Phase 2: FARAPULSE Ablation System	Boston Scientific Corporation	Persistent Atrial Fibrillation	03/25	03/25
Chu, Rosa A
JETi, NCT04370691: Peripheral Thrombectomy Registry	Active, not recruiting	N/A	260	Europe, Canada, US, RoW	JETi Peripheral Thrombectomy System	Abbott Medical Devices	Peripheral Artery Thrombosis, Peripheral Venous Thrombosis	08/24	08/25
EspritBTKPAS, NCT06656364: Esprit BTK Post-Approval Study	Recruiting	N/A	200	US, RoW	Esprit BTK System	Abbott Medical Devices	Chronic Limb-Threatening Ischemia	04/27	05/29
NCT05313165: PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia	Recruiting	N/A	100	US	LimFlow Stent Graft System	LimFlow, Inc.	Critical Limb Ischemia, Chronic Limb-Threatening Ischemia, Peripheral Arterial Disease	05/27	05/27
Chapman, Jennifer
NCT05700149: Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma	Recruiting	N/A	300	Europe, US, RoW		International Extranodal Lymphoma Study Group (IELSG)	Nodal Marginal Zone Lymphoma	12/26	12/26